Orangewood Partners, a private investment firm, has made an investment in Barrington James, a global recruitment firm focused on the pharmaceutical, biotechnology and medical device sectors.
Barrington James provides life sciences companies with recruitment services that combine industry experience with recruitment technology to make talent identification and attraction easier for its clients. The investment aims to enhance Barrington James’ recruiting services, expand its client service capabilities and support its development of technology and software. Barrington James’ founder and CEO, Dan Barrington, will continue to lead the business alongside the existing leadership team.
“All of the whole of the life science and biotech sectors are poised for significant long-term growth, and competition for top talent in virtually every position is continuing to intensify,” says Neil Goldfarb, managing partner of Orangewood. “Barrington James’ deep focus on life sciences uniquely positions it to provide outstanding and highly bespoke service to its clients and capitalize further on this attractive opportunity.
K&L Gates LLP served as legal advisor to Orangewood. Fairmount Partners served as financial advisor to Barrington James and Keystone Law served as its legal advisor. Brightwood Capital Advisors LLC acted as lead arranger and administrative agent for the transaction.